8247 logo

Biosino Bio-Technology and Science Incorporation Stock Price

SEHK:8247 Community·HK$522.4m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

8247 Share Price Performance

HK$3.61
2.77 (329.76%)
HK$3.61
2.77 (329.76%)
Price HK$3.61

8247 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Good value with low risk.

3 Risks
1 Reward

Biosino Bio-Technology and Science Incorporation Key Details

CN¥225.1m

Revenue

CN¥137.8m

Cost of Revenue

CN¥87.2m

Gross Profit

CN¥134.6m

Other Expenses

-CN¥47.3m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
-0.33
38.77%
-21.03%
88.2%
View Full Analysis

About 8247

Founded
1988
Employees
471
CEO
Peng Chen
WebsiteView website
www.sinobio.com.cn

Biosino Bio-Technology and Science Incorporation, together with its subsidiaries, manufactures, sells, and distributes in-vitro diagnostic reagents in Mainland China. The company offers clinical chemistry reagents, including single and double reagents, calibrators, QC products, and washing solution detergents; Elisa kits; rapid tests; and analyzers. It also provides medical and medical inspection services; and produces and sells medical instruments. Biosino Bio-Technology and Science Incorporation Guangdong has a a strategic cooperation agreement with Xiaoshou Medical Technology Co., Ltd. Biosino Bio-Technology and Science Incorporation founded in 1988 and is based in Beijing, the People’s Republic of China.

Recent 8247 News & Updates

Recent updates

No updates